HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for Cannabis/CBD

Schumer Includes Cannabinoid Pathway For Supplements In Cannabis Legalization Draft Bill

Draft bill proposes rules not only on producing and marketing marijuana, but on using in supplements ingredients derived from cannabis plants classified as hemp. Some supplement industry stakeholders see draft as delivering on industry requests but others say it goes too far.

Cannabidiol CBD FDA

TTS Pharma’s CBD Animal Studies Show Anti-Inflammatory Potential

Can cannabinoids provide therapeutic benefits to consumers? A new animal study by the UK's TTS Pharma suggests anti-inflammatory properties for CBD, according to the company's director of Medical Affairs, Rob Walton.

United Kingdom Wellness

Tasting Growth First With Hemp And Cannabis Ingredients, SōRSE Is Hungry For More Markets

SōRSE uses proprietary water-soluble emulsion technology to blend cannabinoids into ingredients its customers use in supplements, food and beverages and topicals. Cannabinoids it works with include THC and it also offers its own cannabis-infused beverage brands.

Cannabidiol CBD Dietary Supplements

Arizona Cannabinoid Supplement Firm Agrees To Stop After Acknowledging 34 False Claims

Arizona CBD marketer Kushly Industries is ordered to no longer make disease claims for products without competent and reliable scientific evidence. Settlement lists 16 examples of claims but order in US district court identifies 32 claims the firm acknowledged it used in advertising.

Dietary Supplements Cannabidiol CBD

For US Hemp Market, Sen. Paul Remains Mobile

Kentucky's junior senator re-introdd legislation to raise from 0.3% to 1% the level of THC by dry weight that Congress defined as legal hemp in the 2018 farm bill.

Cannabidiol CBD Ingredients

Congressional Research Suggests Additional Layer Of Complexity In FDA’s Cannabinoid Puzzle

Congressional Research Service report says in addition to markets for hemp from fiber, seeds and flowers, “a separate, marketable category exists for the plant’s extracted compounds.” Ingredients from hemp seeds and grains as well as from flowers are alternative protein sources in supplements, foods and beverages and dairy alternatives.

Cannabidiol CBD FDA

Naloxone Still On US House Appropriators’ Radar, But OTC Access Remains Off Screen

Committee report again includes item concerning FDA’s work on expanding access to opioid antagonist naloxone. It still doesn’t acknowledge agency’s interest in making drug available OTC in a nasal inhaler, but emphasizes access for pregnant and postpartum women.

FDA Legislation

US House Appropriators Have Little Left To Say About Allowing Cannabinoids In Supplements

Appropriation Committee’s report with FDA’s FY2022 funding bill appears to signal that other than getting something done, members have little to say about establishing lawful use of hemp-derived cannabinoids in non-drug products.

Cannabidiol CBD Dietary Supplements
See All